MedTrace Logo

Euclid Phoenix Lens Design Trial 2

NCT06392607 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-04-30

No results posted yet for this study

Summary

Lens wettability and subjective comfort of Euclid orthokeratology lenses with and without an enhanced coating will be compared in 50 children. Axial elongation will be monitored in pediatric patients who qualify and consent.

Conditions

  • Myopia
  • Cornea

Interventions

DEVICE

Euclid orthokeratology (standard coating)

Lens with the current coating

DEVICE

Euclid orthokeratology (enhanced coating)

Lens with the enhanced coating

Sponsors & Collaborators

  • Euclid Systems Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2025-08-31
Completion
2025-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06392607 on ClinicalTrials.gov